Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Patients create accounts, complete a health questionnaire, consult with a licensed provider via video, and receive prescriptions sent directly to their home
CMS specifically disqualifies beneficiaries diagnosed with type 2 diabetes, moderate to severe obstructive sleep apnea, or noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), and also excludes anyone already filling a GLP-1 prescription under their Part D plan in 2026
M., Hill-Yardin, E
Monitoring & Follow-Up Regular follow-up may include: Blood pressure checks Kidney function tests (creatinine, electrolytes) Cardiovascular risk assessment Proper monitoring enhances safety and therapeutic effectiveness
US$ 29.33
US$ 27.94
US$ 21.44
